glp 1 drinking GLP-1s tied to lower alcohol intake for adults with overweight, obesity Can You Drink on a

The clinical trial evidence on duration The landmark STEP trials for semaglutide and SURMOUNT trials for tirzepatide provide the clearest data on what happens at different treatment durations

Varisco, PharmD, PhD, an assistant professor in the Department of Pharmaceutical Health Outcomes of Policy and assistant director for Research Development in the Prescription Drug Misuse Education and Research Center at the University of Houston College of Pharmacy

The weight-loss boom has created a parallel market and now regulators are stepping in

Reporting side effects: Contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Eli Lilly reports that tirzepatide is in clinical trials for autoimmune conditions in patients with obesity or overweight